RXRX · Insider trading · 13F holders · Congress trades
Recursion Pharmaceuticals, Inc. (RXRX)
Who is buying and selling RXRX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 11
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $644K
- Congress trades, 12 months
- 0
RXRX at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 RXRX insiders filed 5 sales worth $644K on SEC Form 4, and no open-market purchases; 5 of the sales were pre-planned under Rule 10b5-1.
- 11 13F filers hold RXRX among their 50 largest positions, worth $249.2M combined, including Cathie Wood. The biggest bets by portfolio weight are MIC Capital Management UK LLP (9.0%), Nan Fung Group Holdings Ltd (1.7%) and Cathie Wood (1.0%).
- No member of Congress has disclosed a trade in RXRX.
- RXRX last closed at $4.24 on Oct 29, 2026.
RXRX insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 RXRX insiders filed 5 sales worth $644K on SEC Form 4, and no open-market purchases; 5 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Borgeson Blake | Director | Sale10b5-1 | 50,000 | $4.84 | $242K | SEC |
| Oct 7, 2026 | Hershberg Robert | Director | Sale10b5-1 | 25,000 | $5.00 | $125K | SEC |
| Sep 10, 2026 | Khan Najat | CEO and President, Director | Sale10b5-1 | 22,408 | $3.52 | $79K | SEC |
| Sep 2, 2026 | Borgeson Blake | Director | Sale10b5-1 | 30,000 | $3.34 | $100K | SEC |
| Aug 6, 2026 | Borgeson Blake | Director | Sale10b5-1 | 30,000 | $3.25 | $98K | SEC |
Who owns RXRX? Hedge funds and superinvestors
11 13F filers hold RXRX among their 50 largest positions, worth $249.2M combined, including Cathie Wood. The biggest bets by portfolio weight are MIC Capital Management UK LLP (9.0%), Nan Fung Group Holdings Ltd (1.7%) and Cathie Wood (1.0%).
Superinvestors holding RXRX: Cathie Wood 1.0%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Cathie WoodMutual fund manager | 1.0% | $151.7M | 41,337,632 | +2.8% shares | Q2 2026 |
| Softbank Group Corp.Hedge fund | 0.3% | $50.0M | 13,636,515 | +0.0% shares | Q2 2026 |
| MIC Capital Management UK LLPHedge fund | 9.0% | $35.4M | 9,644,033 | +0.0% shares | Q2 2026 |
| Comprehensive Financial Management LLCWealth manager | 0.1% | $3.5M | 941,895 | +0.0% shares | Q2 2026 |
| Pivotal bioVenture Partners Investment Advisor LLCVenture capital | 0.7% | $2.2M | 595,518 | +0.0% shares | Q2 2026 |
| Nan Fung Group Holdings LtdInvestment manager | 1.7% | $2.2M | 595,287 | +0.0% shares | Q2 2026 |
| Carroll Investors, IncWealth manager | 0.8% | $1.8M | 500,349 | -1.8% shares | Q2 2026 |
| Green Alpha Advisors, LLCWealth manager | 0.7% | $989K | 239,404 | — | Q3 2026 |
| Allen Operations LLCInvestment manager | 0.1% | $799K | 217,657 | +0.0% shares | Q2 2026 |
| Casdin Capital, LLCHedge fund | 0.0% | $607K | 165,323 | +0.0% shares | Q2 2026 |
| ADG Wealth Management Group, LLCWealth manager | 0.0% | $43K | 10,479 | +0.0% shares | Q3 2026 |
Each manager counts with its latest 13F (Q3 2026: 2, Q2 2026: 9). Screen RXRX in the grand portfolio →
RXRX stock trades by members of Congress
No member of Congress has disclosed a trade in RXRX.
RXRX questions and answers
Are insiders buying RXRX stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 RXRX insiders filed 5 sales worth $644K on SEC Form 4, and no open-market purchases; 5 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own RXRX?
11 13F filers hold RXRX among their 50 largest positions, worth $249.2M combined, including Cathie Wood. The biggest bets by portfolio weight are MIC Capital Management UK LLP (9.0%), Nan Fung Group Holdings Ltd (1.7%) and Cathie Wood (1.0%).
Has Congress traded RXRX?
No member of Congress has disclosed a trade in RXRX.
Who is the largest holder of RXRX?
Among 13F filers, Cathie Wood reports the largest RXRX position, $151.7M (41,337,632 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is MIC Capital Management UK LLP's: 9.0% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.